Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002667 · ClinicalTrials.gov registry record · NA
Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer
A NA study of Lung Cancer, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- NA
- Development phase
- 1,100
- Enrollment target
- 5
- Study locations
NCT00002667: Completed NA study of Lung Cancer, sponsored by Eastern Cooperative Oncology Group.
NCT00002667 is a NA study of Lung Cancer that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 1,100 participants, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (18% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002667, a NA study of Lung Cancer, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,100 participants
- Enrollment target
- 5
- Study locations
Study Summary
RATIONALE: Using new methods to examine sputum samples for the presence of cancer cells may detect lung cancer earlier. PURPOSE: Screening trial to study the effectiveness of new methods of examining sputum samples to detect second primary lung cancer in patients with resected stage I non-small cell lung cancer.
Conditions Studied
Interventions
- OTHER cytology specimen collection procedure
- PROCEDURE study of high risk factors
- OTHER immunoenzyme technique
Study Locations (5)
Florida
- H. Lee Moffitt Cancer Center and Research Institute - Tampa
Iowa
- CCOP - Iowa Oncology Research Association - Des Moines
New Jersey
- CCOP - Northern New Jersey - Hackensack
Ohio
- Ireland Cancer Center - Cleveland
Pennsylvania
- Allegheny University Hospitals- Hahnemann - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 1995-10-10 |
| Est. Completion | 2004-10-01 |
| Phase | NA |
What the finished NCT00002667 record still lists
NCT00002667 is an interventional study that assigns participants to a tested intervention. Its 1,100 participants enrollment target places it among the larger protocols in the corpus, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (18% higher).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which cytology specimen collection procedure is the first listed.
NCT00002667 lists 5 locations in 5 states (Florida, Iowa, New Jersey).
Frequently Asked Questions
What is clinical trial NCT00002667 about?
NCT00002667 is a clinical study titled "Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer". RATIONALE: Using new methods to examine sputum samples for the presence of cancer cells may detect lung cancer earlier. PURPOSE: Screening trial to study the effectiveness of new methods of examining sputum samples to detect second primary lung cancer in patients with resected stage I non-small cel...
What is the current status of trial NCT00002667?
This trial is currently completed. It is a NA study. The enrollment target is 1,100 participants. The study started on 1995-10-10. Estimated completion is 2004-10-01.
What conditions does trial NCT00002667 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT00002667?
The interventions under investigation include: cytology specimen collection procedure (OTHER), study of high risk factors (PROCEDURE), immunoenzyme technique (OTHER).
Who is sponsoring clinical trial NCT00002667?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002667 being conducted?
This trial has 5 study locations across Florida, Iowa, New Jersey, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00002667's enrollment target sits among peer trials
1,100 44th of 409 higher than 365 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI